This multiple-award Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a leading regenerative medicine company, to provide wound care dressings, surgical implants, and other medical/surgical supplies to support Department of Defense (DoD) healthcare programs. The $49.5 million IDC has a 5-year period of performance from June 2021 through June 2026 and utilizes a total small business set-aside. Organogenesis, a for-profit manufacturer, will deliver products such as APLIGRAF, PURAPLY AM, and NUSHIELD from its facility in Canton, Massachusetts under fixed-price delivery orders. This IDC is part of a larger $183.15 million procurement by DLA to acquire medical and surgical supplies for the DoD. Organogenesis also holds several other significant federal contract vehicles with the Department of Veterans Affairs and DLA, valued up to $30 million, to supply its advanced wound care and tissue regeneration solutions to government healthcare agencies.
The awarded delivery orders under this IDC, valued from hundreds to thousands of dollars, demonstrate Organogenesis' role as a key supplier of regenerative medicine products to the military and veteran populations. The delivery orders cover a range of Organogenesis' wound care dressings, surgical implants, and tissue regeneration products that are used to support tissue repair and wound healing for service members and veterans. While these specific delivery orders do not utilize set-asides, Organogenesis has previously been awarded some federal contracts through small business programs.
Generated 8/20/24, 9:13 AM